BiotechTube
Home/Crinetics Pharmaceuticals/Stephen F. Betz, Ph.D.
SF

Stephen F. Betz, Ph.D.

Founder & Chief Scientific Officer

Crinetics Pharmaceuticals

Therapeutic Areas

Endocrine DiseasesNeuroendocrine Tumors

Crinetics Pharmaceuticals Pipeline

DrugIndicationPhase
Paltusotine (CRN00808)AcromegalyPhase 3
CRN04777Congenital HyperinsulinismPhase 2
CRN04894Cushing’s DiseasePhase 2
CRN01941Neuroendocrine TumorsPhase 1

Leadership Team at Crinetics Pharmaceuticals

RS
R. Scott Struthers, Ph.D.
Founder & Chief Executive Officer
TS
Tobin Schilke
Chief Financial Officer
AS
Alan S. Krasner, M.D.
Chief Endocrinologist
JK
Jeff Knight, M.P.H.
Chief Development & Operating Officer
IK
Isabel Kalofonos
Chief Commercial Officer
CR
Chris Robillard
Chief Business Officer
JK
Jacqueline Kirby
Chief Corporate Affairs Officer
GA
Garlan Adams, J.D.
Chief Legal Officer
AC
Adriana C. Cabré
Chief Human Resources Officer
View full Crinetics Pharmaceuticals profile